TY - JOUR T1 - 40 Hz Auditory Steady-State Responses Predict Clinical Outcomes in Clinical-High-Risk Participants: A MEG Study JF - medRxiv DO - 10.1101/2020.09.25.20201327 SP - 2020.09.25.20201327 AU - Tineke Grent-‘t-Jong AU - Ruchika Gajwani AU - Joachim Gross AU - Andrew I. Gumley AU - Rajeev Krishnadas AU - Stephen M. Lawrie AU - Matthias Schwannauer AU - Frauke Schultze-Lutter AU - Peter J. Uhlhaas Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/04/2020.09.25.20201327.abstract N2 - Objective To examine whether 40-Hz Auditory Steady-State Responses (ASSRs) are impaired in participants at clinical high-risk for psychosis (CHR-P) and predict clinical outcomes.Method Magnetoencephalography data were collected during a 40-Hz ASSR paradigm for a group of 116 CHR-P participants, 33 first-episode-psychosis patients (FEP, 15 antipsychotic-naïve), a psychosis-risk-negative group (CHR-N: n=38) and 49 healthy controls. Analysis of group differences of 40-Hz Inter-trial-phase-coherence (ITPC) and 40-Hz amplitude focused on right Heschl’s gyrus [RHES], superior temporal gyrus, hippocampus [RHIP], and thalamus [RTHA], after establishing significant activations during 40-Hz stimulation. Linear regression and linear discriminant analyses (LDA) were used to predict clinical outcomes, including transition to psychosis and persistence of attenuated psychotic symptoms (APS) in CHR-Ps.Results CHR-P and FEP-patients were impaired in 40-Hz amplitude in RTHA and RHIP. In addition, FEP-patients were impaired in 40-Hz amplitude in RHES and CHR-Ps in 40-Hz ITPC in RHES. 40-Hz ASSR deficits were pronounced in CHR-Ps who later transitioned to psychosis (n=13) or showed persistent APS (n=40). Importantly, both APS-persistence and transition to psychosis were predicted by 40-Hz ASSR impairments. Classification accuracy was 73.7% for non-persistent-APS and 72.5% for persistent-APS group (Area under the curve (AUC)=0.842). For transition risk to psychosis, classification accuracy was 76.7% and 53.8% for non-transitioned and transitioned CHR-P participants, respectively (AUC=0.810).Conclusions Our data indicate that deficits in gamma entrainment in primary auditory cortex and subcortical areas constitute a potential biomarker for predicting clinical outcomes in CHR-P participants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Uhlhaas has received research support from Lilly and Lundbeck outside the submitted work. Dr. Lawrie has received a personal fee from Sunovion outside the submitted work. The study was supported by the Medical Research Council (MR/L011689/1). Dr. Rajeev Krishnadas was supported by the Neurosciences Foundation. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical committees of University of Glasgow and the NHS Research Ethical Committee Glasgow & Greater Clyde.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon reasonable request. ER -